e-Profile Login and ID Quick Search
FDA to Revise GMP Regulations to Help Protect Supply Chain
To help industry secure the pharmaceutical supply chain against economically motivated adulteration, FDA is revising good manufacturing practice (GMP) regulations for incoming raw materials, according to a FDA news Drug Daily Bulletin. Deb Autor, director, Office of Compliance, Center for Drug Evaluation and Research, stated that the revised regulations will significantly improve the control over suppliers. FDA has not yet provided a timeline, but Autor stated that the revisions are under way.
